- Home
- FND vs LNTH Comparison
FND vs LNTH Comparison
Compare FND & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FND | LNTH |
|---|---|---|
| Founded | 2000 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 4.4B |
| IPO Year | 2017 | 2015 |
Fundamental Metrics
Financial Performance| Metric | FND | LNTH |
|---|---|---|
| Price | $65.91 | $69.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 6 |
| Target Price | ★ $82.59 | $78.00 |
| AVG Volume (30 Days) | ★ 2.3M | 1.1M |
| Earning Date | 02-19-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.08 | N/A |
| EPS | 2.00 | ★ 2.39 |
| Revenue | ★ $4,661,833,000.00 | $1,525,933,000.00 |
| Revenue This Year | $6.22 | $0.01 |
| Revenue Next Year | $7.82 | $0.52 |
| P/E Ratio | $32.89 | ★ $29.12 |
| Revenue Growth | ★ 6.04 | 1.95 |
| 52 Week Low | $55.11 | $47.25 |
| 52 Week High | $108.76 | $111.29 |
Technical Indicators
Market Signals| Indicator | FND | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 60.02 | 71.09 |
| Support Level | $60.38 | $66.36 |
| Resistance Level | $63.82 | $67.45 |
| Average True Range (ATR) | 1.97 | 1.69 |
| MACD | 0.39 | -0.01 |
| Stochastic Oscillator | 92.97 | 93.81 |
Price Performance
Historical ComparisonAbout FND Floor & Decor Holdings Inc.
Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.